Product Program year 2020 Source: CMS Open Payments

Voraxaze

Drug Toxicity Antidote Methotrexate Toxicity

Open in the dashboard

General payments

$389,524

121 payments

Research payments

$0

0 payments

Through program year 2020, $389,524 in general payments and $0 in research payments were reported against Voraxaze (Toxicity Antidote Methotrexate Toxicity).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $389,524 121

Breakdown

Who paid General payments · program year 2020
  1. BTG International, Inc. $389,524 121 payments
Top recipients General payments · program year 2020
  1. Scott Howard Pediatric Hematology-Oncology · Memphis, TN $337,000 87% · 3 payments
  2. Anish Ray Pediatric Hematology-Oncology · Fort Worth, TX $10,684 3% · 23 payments
  3. Ut Md Anderson Cancer Center Teaching hospital · TX $10,000 3% · 1 payment
  4. Steven Fein Hematology & Oncology · Miami, FL $6,300 2% · 2 payments
  5. Jaya Kala Nephrology · Houston, TX $5,400 1% · 12 payments

The top 5 of 62 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pediatric Hematology-Oncology Pediatrics $348,060 94% · 24 practitioners
  2. Hematology & Oncology Internal Medicine $11,195 3% · 11 practitioners
  3. Nephrology Internal Medicine $9,458 3% · 2 practitioners
  4. Internal Medicine $281 <1% · 3 practitioners
  5. Diagnostic Radiology Radiology $94 <1% · 1 practitioner

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Tennessee $337,072 87% · 2 recipients
  2. Texas $26,610 7% · 6 recipients
  3. Florida $7,816 2% · 3 recipients
  4. California $4,532 1% · 9 recipients
  5. Pennsylvania $4,393 1% · 7 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

121 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record